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Promoter Variant in the Catalase Gene Is Associated
with Vitiligo in Chinese People
Ling Liu1,3, Chunying Li1,3, Jian Gao1, Kai Li1, Rui Zhang2, Gang Wang1, Chenxin Li1 and Tianwen Gao1
Vitiligo is an acquired depigmentation disorder, and reactive oxygen species have an important role in the
physiology of cell damage. Reduced catalase enzyme activity and accumulation of excessive hydrogen peroxide
have been observed in vitiligo. In a hospital-based case–control study of vitiligo patients (n¼ 749) and age- and
sex-matched healthy controls (n¼ 763), we investigated three catalase (CAT) gene polymorphisms (89A4T,
389C4T, and 419C4T) to examine whether CAT gene polymorphisms are associated with vitiligo susceptibility
in the Chinese population. The case–control analysis revealed a 1.54-fold (95% confidence interval (CI) 1.25–1.91)
increased risk of developing vitiligo for 89A4T genotype carriers. No evidence for any association between
389C4T and 419C4T polymorphisms in the catalase gene and vitiligo susceptibility was found. An analysis of
haplotypes showed increased risk for T89C389 (odds ratio (OR) 1.90, 95% CI 1.26–2.86) and T89T389 (OR 2.80, 95%
CI 1.24–6.30). Logistic regression analysis of catalase activity also showed a dose–response relationship between
increased risk and decreased activity in CAT 89A4T variant genotype carriers, especially in vitiligo patients
(Ptrend o0.001). Our molecular epidemiologic findings suggest that the CAT 89A4T variant genotypes were
associated with a significant decrease in catalase enzyme activity and a genetic predisposition for vitiligo
in Chinese people.
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INTRODUCTION
Vitiligo is a common, chronic skin disorder resulting from
selective destruction of melanocytes. The disease affects
individuals of both sexes, with a prevalence ranging from 0.1
to 8.8% worldwide (Handa and Kaur, 1999; Herane, 2003;
Gautam et al., 2006). In China, the incidence rate of vitiligo is
approximately 0.09%, without a propensity for male or female,
and has increased in the past decade (Gautam et al., 2006; Lu
et al., 2007). There is much debate over the precise
pathogenesis of the depigmentation, including autoimmune,
biochemical, neural, self-destructive, and genetic hypotheses
(Castanet and Ortonne, 1997; Shaffrali and Gawkrodger, 2000).
In recent years, oxidative stress has attracted much attention,
and some findings have suggested that oxidative stress may be
the triggering event in the melanocyte degeneration of vitiligo
(Passi et al., 1998; Jimbow et al., 2001; Boisseau-Garsaud et al.,
2002; Rokos et al., 2002; Yildirim et al., 2003; Kocaturk et al.,
2004; Ines et al., 2006; Arican and Kurutas, 2008).
Oxidative stress is the condition of prooxidant/antioxidant
disequilibrium (Sies, 1991). Reactive oxygen species can be
generated by mitochondria through enzyme complexes
during normal processes of oxidative phosphorylation and
can cause cell injury and death (Arita et al., 2006; Rezvani
et al., 2006). Previous studies of vitiliginous melanocytes
showed that an imbalance between oxidative and anti-
oxidative patterns, such as the accumulation of hydrogen
peroxide (H2O2) and low catalase (CAT) level/activity, may
induce the destruction of melanocytes (Schallreuter, 1999;
Rokos et al., 2002; Hasse et al., 2004; Schallreuter et al.,
2004; Maresca et al., 2007).
The cause of low CAT level/activity in vitiligo patients has
not been determined. In addition to substrate inhibition of
CAT activity by high H2O2 levels in the epidermis of vitiligo
patients, allelic variants in the CAT gene may have
deleterious effects on the expression or function of CAT
(Go´th et al., 2004). The human CAT gene is located on
chromosome 11p13, consisting of 13 exons and 12 introns.
A number of CAT gene single-nucleotide polymorphisms
(SNPs) and mutations have been associated with disease
manifestations such as catalasemia/hypocatalasemia, hyper-
tension, and type 2 diabetes mellitus in various races
(Go´th and Eaton, 2000; Forsberg et al., 2001; Go´th et al.,
2001; Jiang et al., 2001). Single polymorphisms located in
the promoter region could influence rates of transcription,
resulting in low CAT expression (Go´th and Vitai, 1997; Park
et al., 2006). Although the C4T SNP in codon 389 of exon 9
(rs769217) is a silent substitution, it has been associated with
susceptibility to vitiligo in a North American population and
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an English population in the United Kingdom (Casp et al.,
2002; Gavalas et al., 2006). However, no difference in allelic
and genotypic occurrences was observed in Korean people in
a study with a relatively small sample size (Park et al., 2006).
The C4T SNP in codon 419 of exon 10 (rs11032709) is also
a silent substitution, whose distribution of alleles and
genotypes differs among races, and the variant genotype
could be associated with susceptibility to vitiligo (Casp et al.,
2002).
Although there have been some reports of an association
between CAT polymorphisms and risk of various diseases,
the genotype distributions of the CAT polymorphisms vary
with ethnicity, and until now, no study has been carried out
on the association between the three CAT polymorphisms
and vitiligo risk in the Chinese population. Therefore,
we hypothesized that the three CAT gene polymorphisms
(89A4T, 389C4T, and 419C4T) were associated with the
risk of vitiligo (Figure 1a) and tested this hypothesis in our
hospital-based case–control study of 749 vitiligo patients and
763 vitiligo-free control subjects.
RESULTS
Characteristics of study subjects
This analysis included 749 Han Chinese patients with vitiligo
and 763 age- and sex-matched controls. The demographic
and clinical characteristics and the frequencies of alleles and
genotypes in control and vitiligo patients were provided as
we have described previously. The mean age was 24.7±13.6
years for cases and 26.4±13.3 years for controls (P¼0.667).
The frequency distributions in men and women were 55.3%
(n¼414) and 44.7% (n¼335), respectively, in the cases and
54.1% (n¼413) and 45.9% (n¼ 350) in the controls
(P¼0.655) (Liu et al., 2009).
Genotype distribution of CAT polymorphisms between cases
and controls
The distributions of CAT 89A4T and CAT 389C4T
genotypes among cases and controls are shown in Table 1.
The distributions of all genotypes among control subjects
were in agreement with the Hardy–Weinberg equili-
brium (w2¼0.473, P¼0.492 for 89A4T; and w2¼0.006,
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Figure 1. Location and detection of catalse (CAT) and single-nucleotide polymorphisms (SNPs). (a) CAT gene structure and the location of selected SNPs.
The human CAT gene is mapped to chromosome 11p13. The rs7943316 is an A-to-T transition at 89 base pairs from the transcription site. The rs769217
is a C-to-T substitution in exon 9 and rs11032709 is a C-to-T substitution in exon 10. (b) Sequence analyses of the CAT PCR products using an ABI
PRISM 3700 (Carlsbad, CA) automatic sequencer.
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P¼0.937 for 389C4T). The CAT 89 variant T allele
frequency was significantly higher among the cases than
among the controls (P¼0.001). Consistent with the T allele
distribution, the frequencies of variant genotypes (AT and TT)
were significantly higher among the cases than among the
controls (48.5 vs. 39.2% and 9.2 vs. 8.2%, Po0.001). When
we used the AA genotype as the reference, we found that
the AT genotype was associated with a higher risk of vitiligo
(adjusted odds ratio (OR) 1.54; 95% confidence interval (CI)
1.25–1.91), whereas the TT genotype was associated with
a borderline increased vitiligo risk (adjusted OR 1.40; 95% CI
0.96–2.03). We found that the trend test was also significant
(Ptrend o0.001). There was no evidence that CAT 389C4T
was associated with susceptibility to vitiligo (P¼0.604 for
variant T allele frequency). For CAT 419C4T, the T allele
could not be detected in any of the control subjects or the
vitiligo patients; thus all individuals recruited in this study
were homozygous for the C allele.
Association between CAT haplotypes and risk of vitiligo
The interaction of multiple SNPs within a haplotype can
affect biological phenotype (Drysdale et al., 2000). Hence,
we analyzed the effect of CAT 89A4T and CAT 389C4T
on the risk of vitiligo in the context of haplotype, using SAS
software (version 10.0; SAS Institute, Cary, NC). We observed
that the two CAT SNPs were in linkage disequilibrium
(D¼0.652, Po0.001), suggesting that a joint effect between
the two SNPs may exist. Four possible CAT haplotype alleles
were derived from the known genotypes (i.e., A89C389 ,
A89T389, T89C389, and T89T389 alleles), and the distri-
butions of the four haplotypes between the cases and the
controls were statistically significantly different (Po0.001;
Table 2). Compared with the A89C389 haplotype, the
haplotypes containing the 89T allele were associated
with an increased risk of vitiligo (for T89C389, adjusted OR
1.90, 95% CI 1.26–2.86; and for T89T389, adjusted OR 2.80,
95% CI 1.24–6.30.)
Risk of vitiligo associated with CAT 89A4T genotype by
389C4T genotype
We also examined whether there was a statistical interaction
between CAT 89A4T and 389C4T (Table 3). Participants
carrying only one risk genotype of 89TT or 389TT had an
OR of 1.80 (95% CI 1.08–3.00) or 1.38 (95% CI 0.91–2.10)
for developing vitiligo, respectively, compared with those
who were homozygous wild type for both SNPs. It was
observed that the patients carrying the CAT 89AT genotype
were more likely to carry the CAT 389TT genotype than the
controls. Patients carrying two risk genotypes of 89AT
and 389TT had an OR of 3.00 (95% CI 1.59–5.64), which is
larger than the product (1.80 1.38¼2.48) of the OR for
participants carrying only one risk genotype (Po0.01, test
for overall interaction), compared with those who were
homozygous wild type for both SNPs. These results suggest
an interaction between the CAT 89A4T and the CAT
389C4T genotypes intensifying the risk of developing
vitiligo.
Logistic regression analysis of CAT activity in vitiligo patients
and controls
We tested serum CAT activity in 244 vitiligo patients and
259 age- and sex-matched controls whose demographic and
clinical characteristics and frequencies of alleles and genotypes
were in concordance with the overall samples (744 cases and
Table 1. Genotype and allele frequencies of the CAT
polymorphism among the cases and controls and
associations with the risk of vitiligo
Cases
(N=749)
Controls
(N=763)1
Genotype N % N % P-value2 OR (95% CI)3
89A4T
AA 317 42.3 401 52.6 o0.001* 1.00 (Reference)
AT 363 48.5 299 39.2 1.54 (1.25–1.91)
TT 69 9.2 63 8.2 1.40 (0.96–2.03)
T allele — 33.4 — 27.9 0.001 —
Ptrend o0.0014
389C4T
CC 240 32.0 256 33.6 0.822 1.00 (Reference)
CT 372 49.7 371 48.6 1.07 (0.85–1.34)
TT 137 18.3 136 17.8 1.07 (0.80–1.44)
T allele — 43.1 — 42.1 0.604 —
Abbreviations: CAT, catalase; CI, confidence interval; OR, odds ratio.
1The observed genotype frequencies among the controls were in
agreement with the Hardy–Weinberg equilibrium (w2=0.473, P=0.492
for 89A4T; and w2=0.006, P=0.937 for 389C4T).
2Two-tailed w2 test for either genotype distributions or allele frequencies
between the cases and controls: * for distribution of three genotypes.
3ORs were obtained from a logistic regression model with adjustment for
age and sex.
4P-values were obtained in a logistic regression model adjusted by age
and sex.
Table 2. Frequencies of the CAT haplotypes among
the cases and controls and associations with the risk of
vitiligo
Cases
(N=1,498)
Controls
(N=1,526)
Haplotype allele1 N % N % OR (95% CI)2
A89C389 433 28.9 520 34.1 1.00 (Reference)
A89T389 565 37.7 581 38.1 1.29 (0.89–1.86)
T89C389 419 28.0 363 23.8 1.90 (1.26–2.86)
T89T389 81 5.4 62 4.0 2.80 (1.24–6.30)
Abbreviations: CAT, catalase; CI, confidence interval; OR, odds ratio.
1LD (linkage disequilibrium) analysis: D=0.652, Po0.001 (for the
differences in haplotype allele distributions between cases and controls).
2ORs were obtained from a logistic regression model with adjustment for
age and sex.
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763 controls; data not shown). We performed a logistic
regression analysis of CAT activity in vitiligo patients and
controls (Table 4). When the CAT activity was dichotomized
by the median activity of the controls, higher activity was
associated with a 0.52-fold reduced risk for vitiligo (95% CI
0.37–0.74). Furthermore, when the CAT activity was divided
into quartiles according to the controls’ activity, a dose–
response relationship between decreased risk and increased
activity was evident: suboptimal (upper tertile), intermediate
(midtertile), and efficient (lower tertile) activities were associated
with the adjusted ORs of 1.00, 0.46 (95% CI 0.30–0.69), and
0.42 (95% CI 0.28–0.65; Ptrend o0.001), respectively.
Risk of vitiligo associated with CAT 89A4T genotypes
by CAT activity
We further estimated the risk of vitiligo associated with CAT
89A4T genotypes by CAT activity (Table 5). CAT 89A4T
genotypes were divided into two categories: 1 and 2 risk
genotypes (89AT or 89TT) and 0 risk genotype (89AA).
When we used 1 and 2 risk genotypes as the reference (89AT
or 89TT), the individuals with 0 risk genotype and higher
CAT activity (X76.15) showed a larger decrease in the risk of
vitiligo (adjusted OR 0.21, 95% CI 0.12–0.38). Consistent with
the preceding results, when the CAT activity was divided into
quartiles according to the controls’ activity, a dose–response
relationship between decreased risk and increased activity was
obvious (Ptrend o0.001). The 89AA genotype with higher
CAT activity was associated with increased protection against
vitiligo (86.97–65.6, adjusted OR 0.34, 95% CI 0.18–0.62;
X86.97, adjusted OR 0.14, 95% CI 0.06–0.31).
DISCUSSION
The past two decades have seen reports of increased
epidermal oxidative stress in the cutaneous epidermis of
vitiligo patients and suggesting that increased prooxidant
activities and reduced antioxidant activities can lead to
elevated levels of H2O2 (Hazneci et al., 2005; Spencer et al.,
2007). CAT has an important role in protecting cells against
severe oxidative stress, and allelic variants in the CAT gene
could have deleterious effects on the expression or function
Table 3. Risk of vitiligo associated with CAT HinfI genotypes by BstXI genotype
89A4T genotype
389C4T genotype AA1 OR (95% CI)2 AT1 OR (95% CI)2 TT1 OR (95% CI)2
CC 61/98 1.00 (Reference) 127/112 1.82 (1.21–2.75) 52/46 1.80 (1.08–3.00)
CT 158/190 1.33 (0.90–1.95) 199/167 1.90 (1.30–2.78) 15/14 1.78 (0.80–3.95)
TT 98/113 1.38 (0.91–2.10) 37/20 3.00 (1.59–5.64) 2/3 1.08 (0.18–6.62)
Abbreviations: CAT, catalase; CI, confidence interval; OR, odds ratio.
1Number of cases/number of controls.
2ORs were obtained from a logistic regression model with adjustment for age and sex.
Po0.001, test for overall interaction.
Table 4. Logistic regression analysis of CAT activity
(nmolmin–1ml–1) in vitiligo patients and controls
Cases (N=244) Controls (N=259)
Activity N % N % OR (95% CI)1
By median
o76.15 165 66.0 150 50.0 1.00 (Reference)
X76.15 85 34.0 150 50.0 0.52 (0.37–0.74)
By tertile
o65.60 134 53.6 99 33.0 1.00 (Reference)
65.60–86.97 61 24.4 101 33.7 0.46 (0.30–0.69)
X86.97 55 22.0 100 33.3 0.42 (0.28–0.65)
Trend test — — — — Po0.0012
Abbreviations: CAT, catalase; CI, confidence interval; OR, odds ratio.
1ORs were obtained from a logistic regression model with adjustment for
age and sex.
2Adjusted for age and sex.
Table 5. Risk of vitiligo associated with CAT HinfI
genotypes by CAT activity
CAT -89A4T
(cases/controls)
Activity
1 And 2
risk genotypes
OR
(95% CI)1
0 Risk
genotype
OR
(95% CI)1
By median
o76.15 80/77 1.00 (Reference) 85/73 1.12 (0.72–1.74)
X76.15 67/66 0.98 (0.62–1.56) 18/84 0.21 (0.12–0.38)
By tertile
o65.60 62/52 1.00 (Reference) 72/48 1.26 (0.75–2.12)
86.97–65.60 38/43 0.75 (0.42–1.33) 23/58 0.34 (0.18–0.62)
X86.97 47/48 0.83 (0.48–1.44) 8/51 0.14 (0.06–0.31)
Trend test — — — Po0.0012
Abbreviations: CAT, catalase; CI, confidence interval; OR, odds ratio.
1ORs were obtained from a logistic regression model with adjustment for
age and sex.
2Adjusted for age and sex.
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of CAT, which may result in high sensitivity to H2O2
(Go´th et al., 2004).
We investigated whether genetic polymorphisms in CAT
contribute to the risk of developing vitiligo. In the hospital-
based case–control study of 749 vitiligo patients and 763
vitiligo-free controls, we demonstrated a statistically signi-
ficant increased risk of vitiligo associated with the variant
CAT 89A4T genotypes, but no evident risk was asso-
ciated with the 389C4T or 419C4T variant genotypes.
In the combined analysis of the variant alleles of CAT, the
genotypes with more variant alleles were associated with
a higher risk of vitiligo. Moreover, we observed a signi-
ficant interaction between the CAT 89AT genotype and the
CAT 389C4T variant genotype. The results suggested that
the CAT promoter region polymorphisms may affect
CAT expression and the risk of vitiligo in the Chinese
population.
The variant promoter sequence region can bind different
transcription factors, resulting in observed differences in
promoter activity, which may provide a clue for future
epidemiological association studies (Forsberg et al., 2001).
The association of CAT 89A4T SNP polymorphisms with
vitiligo risk has been studied in the Korean population (Park
et al., 2006). But in the small sample size study of 118 cases
and 200 controls, no evidence was found that the 89A4T
variant genotype was associated with a significantly in-
creased risk of vitiligo. In contrast, our study showed that the
89AT genotype was associated with a significantly in-
creased risk of vitiligo in Chinese people, whereas the 89TT
genotype was associated with a borderline increased vitiligo
risk. Compared with homozygous carriers of the T allele,
there seemed to be a disparity in the increased risk for
heterozygotes. We inferred that there might be unknown
polymorphisms nearby that interfered with the phenotype,
and hence the heterozygotes showed a higher risk.
The CAT 389C4T and 419C4T genotypes result in silent
substitution of aspartic acid and leucine residue, respectively.
Compared with the previous data, our results indicate that the
genotype distributions of the two CAT polymorphisms vary
with ethnicity. CAT 389C4T was associated with suscepti-
bility to vitiligo in a North American population, and similar
results were found in an English population in the United
Kingdom (Casp et al., 2002; Gavalas et al., 2006). CAT
389C4T may be linked to other CAT mutations that
are deleterious to the expression or the activity of CAT, but
no evidence showed that CAT 389C4T was associated
with the susceptibility to vitiligo (adjusted OR 0.48, 95% CI
0.26–0.90). For CAT 419C4T, nearly all the subjects
analyzed in a North American population were homozygous
for the T allele (Casp et al., 2002). Conversely, the T allele
could not be detected in any of our vitiligo patients,
indicating that all individuals recruited in our study
were homozygous for the C allele. In the Chinese population,
CAT 389C4T and 419C4T have no influence on the risk
of vitiligo.
The interaction of multiple SNPs within a haplotype can
affect biological phenotype (Drysdale et al., 2000). Although
CAT 389C4T had no influence on the risk of vitiligo, we
found that the CAT 89A4T and 389C4T variants may have
a joint effect on the risk for vitiligo when we analyzed
the effects of these two CAT polymorphisms together in
the context of haplotype. Compared with the wild-type
haplotype, the haplotypes containing more variant alleles
were associated with a higher risk of vitiligo. Patients with
the T89T389 haplotype were at nearly threefold increased
risk, and the 89ATþ TT389CTþ TT combined genotype
was significantly associated with susceptibility to vitiligo. The
multiplicative interaction between CAT 89AT and 389C4T
genotypes suggested a statistical interaction between the two
SNPs (Brennan, 2002). The biological phenotype is the result
of the synergistic effect of CAT 89A4T and 389C4T within
a haplotype.
As early as in the 1990s, decreased CAT activity was found
in the epidermis of vitiligo patients, resulting in more
sensitivity of melanocytes to oxidative stress (Schallreuter
et al., 1991). Low CAT activity in blood was also proven to be
associated with diabetes or dyslipidemia (Kosmidou et al.,
2009; Takemoto et al., 2009). On one hand, low CAT levels
reflect inactivation by high concentrations of H2O2; on the
other, variants in the CAT gene have detrimental effects on
the expression or function of CAT (Wood et al., 2008). We
evaluated serum CAT activity, and a dose–response relation-
ship existed in the deleterious effect of low CAT levels.
Comprehensive analysis of CAT activity and CAT 89A4T
genotypes suggested that, much as with antioxidants, the
89A4T wild genotype played an important role in
protection from oxidative damage. Individuals with higher
CAT activity and the 89A4T wild genotype might have a
minor risk for developing vitiligo compared with those with
low CAT activity and a 89A4T variant genotype. High CAT
activity and the CAT 89A allele indicate protection against
oxidative damage in the Chinese population.
In summary, to our knowledge, this is the first report that
CAT promoter region polymorphisms may decrease CAT
expression and activity and affect the risk of vitiligo in the
Chinese population. The CAT 89A4T variant genotypes
were associated with susceptibility to vitiligo and had
interactions with other polymorphisms in exons. There also
exists a dose–response relationship between increased risk
and decreased CAT activity. Because of uncontrolled biases
in the selection of subjects and limited sample size, larger
and population-based studies with inclusion of more SNPs in
genes involved in oxidant stress are warranted to confirm
these findings. Furthermore, studies are necessary to evaluate
whether CAT 89A4T creates a transcriptional factor
binding site or other potential transcriptional mechanisms
behind it.
MATERIALS AND METHODS
Study subjects
A total of 749 vitiligo patients and 763 control subjects were
recruited from Xijing Hospital, Fourth Military Medical University.
Only Han Chinese patients were included in this analysis to avoid
the variance of genotype frequencies among different ethnic groups.
None of the patients had had any therapy in the past 6 months. The
vitiligo-free control subjects were individuals who had come to the
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hospital for a health examination and had no blood relationship with
the vitiligo patients. We used a questionnaire to obtain demographic
and other information (stage, clinical type, onset age, and family
history), and frequency matched the controls to the cases by age
(±5 years), sex, and ethnicity. Genomic DNA was extracted by
standard procedure from the peripheral blood of each subject,
collected after informed consent had been obtained. The research
protocol was approved by the ethics review board of the Fourth
Military University. The study was conducted according to the
Declaration of Helsinki Principles.
Polymorphisms and genotyping
The CAT (89A4T, 389C4T, and 419 C4T) polymorphisms were
determined using the PCR–restriction fragment length polymorphism
method. PCR amplications were generated using the following
primers: for CAT 89A4T, forward 50-AATCAGAAGGCAGTCC
TCCC-30 and reverse 50-TCGGGGAGCACAGAGTGTAC-30 (product
of 250 bp); for CAT 389C4T, forward 50-GCCGCCTTTTTGCCTA
TCCT-30 and reverse 50-TCCCGCCCATCTGCTCCAC-30 (product of
202 bp); for CAT 419C4T, forward 50-CCTAAGTGCATCTGGGT
GGT-30 and reverse 50-TACATCAGACAGTTGGGGCA-30 (product
of 230 bp). PCR was performed using 50 ng DNA as a template under
the following conditions: 94 1C for 10minutes, then 30 cycles of
94 1C for 55 seconds, annealing temperature (89A4T at 66 1C,
389C4T at 69.5 1C, and 419C4T at 60.5 1C) for 55 seconds and
72 1C for 90 seconds, and final extension at 72 1C for 10minutes.
After affinity membrane purification, the PCR products were
subjected to cycle sequencing with the respective forward and
reverse primers. The HinfI, BstXI, and BstNI restriction enzymes
(New England Biolabs, Ipswich, MA, UK) were used to delineate the
CAT 89A4T, 389C4T and 419C4T polymorphisms, respectively.
Restriction fragment length polymorphism–PCR was used to analyze
89A4T, using HinfI to digest the 250 bp PCR amplification
products, which resulted in 177 and 73 bp fragments in the case of
the A allele. In addition, 389C4T was analyzed by restriction
fragment length polymorphism–PCR with BstXI, which cuts only the
T allele, resulting in 108 and 94 bp fragments. The 419C4T
polymorphism was analyzed by restriction fragment length poly-
morphism–PCR with BstNI, which cuts only the C allele (Figure 1b).
More than 10% of the samples were randomly selected and
genotyped again with the same method to test the discrepancy rate,
and the results were 100% concordant.
CAT activity
The blood of each subject was collected without anticoagulant and
then clotted for 30minutes at room temperature. Samples were
centrifuged at 2,000g for 15minutes at 4 1C. The top yellow serum
layer was pipetted off and frozen at 80 1C. Serum activity of CAT
was measured by peroxidatic function using the Cayman CAT assay
kit (Ann Arbor, MI, catalog no. 707002). The detection was based on
the reaction of the enzyme with methanol in the presence of an
optimal concentration of H2O2.
Statistical analysis
We used the w2 test to evaluate the differences in frequency
distributions of selected demographic variables, including each
allele and genotype of the CAT polymorphisms and serum CAT
activity between the cases and the controls. Because of the potential
joint effects of the different CAT polymorphisms on vitiligo risk, the
associations between the combined genotypes of the CAT 89A4T,
CAT 389C4T, and CAT 419C4T polymorphisms and vitiligo risk
were evaluated. Unconditional univariate and multivariate logistic
regression analyses were performed to obtain the crude and adjusted
ORs for the risk of vitiligo and their 95% CIs. The multivariate
adjustment included age and sex. Two-tailed tests of statistical
significance were performed using the SAS software (version 10.0;
SAS Institute). P-values of o0.05 were considered statistically
significant.
CONFLICT OF INTEREST
The authors state no conflict of interest.
ACKNOWLEDGMENTS
We thank Li Yang and Lin Gao for assistance in recruiting the subjects.
REFERENCES
Arican O, Kurutas EB (2008) Oxidative stress in the blood of patients with active
localized vitiligo. Acta Dermatovenerol Alp Panonica Adriat 17:12–6
Arita Y, Harkness SH, Kazzaz JA et al. (2006) Mitochondrial localization
of catalase provides optimal protection from H2O2-induced cell death
in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 290:
L978–86
Boisseau-Garsaud AM, Garsaud P, Lejoly-Boisseau H et al. (2002) Increase in
total blood antioxidant status and selenium levels in black patients with
active vitiligo. Int J Dermatol 41:640–2
Brennan P (2002) Gene–environment interaction and aetiology of cancer:
what does it mean and how can we measure it? Carcinogenesis 23:381–7
Casp CB, She JX, McCormack WT (2002) Genetic association of the catalase
gene (CAT) with vitiligo susceptibility. Pigment Cell Res 15:62–6
Castanet J, Ortonne JP (1997) Pathophysiology of vitiligo. Clin Dermatol
15:845–51
Drysdale CM, McGraw DW, Stack CB et al. (2000) Complex promoter and
coding region beta 2-adrenergic receptor haplotypes alter receptor
expression and predict in vivo responsiveness. Proc Natl Acad Sci USA
97:10483–8
Forsberg L, Lyrenas L, de Faire U et al. (2001) A common functional C-T
substitution polymorphism in the promoter region of the human
catalase gene influences transcription factor binding, reporter gene
transcription and is correlated to blood catalase levels. Free Radic Biol
Med 30:500–5
Gautam DK, Misro MM, Chaki SP et al. (2006) H2O2 at physiological
concentrations modulates Leydig cell function inducing oxidative stress
and apoptosis. Apoptosis 11:39–46
Gavalas NG, Akhtar S, Gawkrodger DJ et al. (2006) Analysis of allelic variants
in the catalase gene in patients with the skin depigmenting disorder
vitiligo. Biochem Biophys Res Commun 345:1586–91
Go´th L, Eaton JW (2000) Hereditary catalase deficiencies and increased risk of
diabetes. Lancet 356:1820–1
Go´th L, Rass P, Pa´y A (2004) Catalase enzyme mutations and their association
with diseases. Mol Diagn 8:141–9
Go´th L, Rass P, Madarasi I (2001) A novel catalase mutation detected by
polymerase chain reaction-single strand conformation polymorphism,
nucleotide sequencing, and Western blot analyses is responsible for the
type C of Hungarian acatalasemia. Electrophoresis 22:49–51
Go´th L, Vitai M (1997) Polymorphism of 50 of the catalase gene in Hungarian
acatalasemia and hypocatalasemia. Electrophoresis 18:1105–8
Handa S, Kaur I (1999) Vitiligo: clinical findings in 1436 patients. J Dermatol
26:653–7
Hasse S, Gibbons NC, Rokos H et al. (2004) Perturbed 6-tetrahydrobiopterin
recycling via decreased dihydropteridine reductase in vitiligo: more
evidence for H2O2 stress. J Invest Dermatol 122:307–13
2652 Journal of Investigative Dermatology (2010), Volume 130
L Liu et al.
Polymorphisms of Catalase Gene and Vitiligo Risk
Hazneci E, Karabulut AB, Ozturk C et al. (2005) A comparative study of
superoxide dismutase, catalase, and glutathione peroxidase activities
and nitrate levels in vitiligo patients. Int J Dermatol 44:636–40
Herane MI (2003) Vitiligo and leukoderma in children. Clin Dermatol
21:283–95
Ines D, Sonia B, Riadh BM et al. (2006) A comparative study of
oxidant–antioxidant status in stable and active vitiligo patients. Arch
Dermatol Res 298:147–52
Jiang Z, Akey JM, Shi J et al. (2001) A polymorphism in the promoter region of
catalase is associated with blood pressure levels. Hum Genet 109:95–8
Jimbow K, Chen H, Park JS et al. (2001) Increased sensitivity of melanocytes
to oxidative stress and abnormal expression of tyrosinase-related protein
in vitiligo. Br J Dermatol 144:55–65
Kocaturk PA, Kavas GO, Cebeci SA (2004) Endothelin-1 induced alterations
in oxidative–nitrosative stress markers. Saudi Med J 25:1835–8
Kosmidou M, Hatzitolios AI, Molyva D et al. (2009) An association study
between catalase 262C4T gene polymorphism, sodium–lithium
countertransport activity, insulin resistance, blood lipid parameters and
their response to atorvastatin, in Greek dyslipidaemic patients and
normolipidaemic controls. Free Radic Res 43:385–9
Liu L, Li C, Gao J et al. (2009) Genetic polymorphisms of glutathione
S-transferase and risk of vitiligo in the Chinese population. J Invest
Dermatol 129:2646–52
Lu T, Gao T, Wang A et al. (2007) Vitiligo prevalence study in Shaanxi
Province, China. Int J Dermatol 46:47–51
Maresca V, Flori E, Briganti S et al. (2007) Correlation between melanogenic
and catalase activity in in vitro human melanocytes: a synergic strategy
against oxidative stress. Pigment Cell Melanoma Res 21:200–5
Park HH, Ha E, Uhm YK et al. (2006) Association study between catalase
gene polymorphisms and the susceptibility to vitiligo in Korean
population. Exp Dermatol 15:377–80
Passi S, Grandinetti M, Maggio F et al. (1998) Epidermal oxidative stress in
vitiligo. Pigment Cell Res 11:81–5
Rezvani HR, Mazurier F, Cario-Andre M et al. (2006) Protective effects of
catalase overexpression on UVB-induced apoptosis in normal human
keratinocytes. J Biol Chem 281:17999–8007
Rokos H, Beazley WD, Schallreuter KU (2002) Oxidative stress in vitiligo:
photo-oxidation of pterins produces H(2)O(2) and pterin-6-carboxylic
acid. Biochem Biophys Res Commun 292:805–11
Schallreuter KU (1999) Successful treatment of oxidative stress in vitiligo. Skin
Pharmacol Appl Skin Physiol 12:132–8
Schallreuter KU, Elwary SM, Gibbons NC et al. (2004) Activation/deactivation
of acetylcholinesterase by H2O2: more evidence for oxidative stress in
vitiligo. Biochem Biophys Res Commun 315:502–8
Schallreuter KU, Wood JM, Berger J (1991) Low catalase levels in the
epidermis of patients with vitiligo. J Invest Dermatol 97:1081–5
Shaffrali F, Gawkrodger D (2000) Management of vitiligo. Clin Exp Dermatol
25:575–9
Sies H (1991) Role of reactive oxygen species in biological processes. Klin
Wochenschr 69:965–8
Spencer JD, Gibbons NC, Rokos H et al. (2007) Oxidative stress via hydrogen
peroxide affects proopiomelanocortin peptides directly in the epidermis
of patients with vitiligo. J Invest Dermatol 127:411–20
Takemoto K, Tanaka M, Iwata H et al. (2009) Low catalase activity in blood is
associated with the diabetes caused by alloxan. Clin Chim Acta 407:43–6
Wood JM, Gibbons NC, Chavan B et al. (2008) Computer simulation of
heterogeneous single nucleotide polymorphisms in the catalase gene
indicates structural changes in the enzyme active site, NADPH-binding
and tetramerization domains: a genetic predisposition for an altered
catalase in patients with vitiligo? Exp Dermatol 17:366–71
Yildirim M, Baysal V, Inaloz HS et al. (2003) The role of oxidants and
antioxidants in generalized vitiligo. J Dermatol 30:104–8
www.jidonline.org 2653
L Liu et al.
Polymorphisms of Catalase Gene and Vitiligo Risk
